User profiles for Fabienne Krauer

Fabienne Krauer

LSHTM
Verified email at lshtm.ac.uk
Cited by 2519

[HTML][HTML] Sirolimus and kidney growth in autosomal dominant polycystic kidney disease

AL Serra, D Poster, AD Kistler, F Krauer… - … England Journal of …, 2010 - Mass Medical Soc
Background In autosomal dominant polycystic kidney disease (ADPKD), aberrant activation
of the mammalian target of rapamycin (mTOR) pathway is associated with progressive …

[HTML][HTML] Zika virus infection as a cause of congenital brain abnormalities and Guillain–Barré syndrome: systematic review

F Krauer, M Riesen, L Reveiz, OT Oladapo… - PLoS …, 2017 - journals.plos.org
Background The World Health Organization (WHO) stated in March 2016 that there was
scientific consensus that the mosquito-borne Zika virus was a cause of the neurological disorder …

[HTML][HTML] Zika virus as a cause of neurologic disorders

N Broutet, F Krauer, M Riesen… - … England Journal of …, 2016 - Mass Medical Soc
Zika Virus as a Cause of Neurologic Disorders | NEJM Skip to main content NEJM Group
Follow Us Facebook Twitter Instagram YouTube LinkedIn Prepare to become a physician, build …

Human ectoparasites and the spread of plague in Europe during the Second Pandemic

KR Dean, F Krauer, L Walløe… - Proceedings of the …, 2018 - National Acad Sciences
Plague, caused by the bacterium Yersinia pestis, can spread through human populations by
multiple transmission pathways. Today, most human plague cases are bubonic, caused by …

[HTML][HTML] Increases in kidney volume in autosomal dominant polycystic kidney disease can be detected within 6 months

AD Kistler, D Poster, F Krauer, D Weishaupt, S Raina… - Kidney international, 2009 - Elsevier
Kidney volume growth is considered the best surrogate marker predicting the decline of
renal function in autosomal dominant polycystic kidney disease. To assess the therapeutic …

[HTML][HTML] Patients with autosomal dominant polycystic kidney disease have elevated fibroblast growth factor 23 levels and a renal leak of phosphate

I Pavik, P Jaeger, AD Kistler, D Poster, F Krauer… - Kidney international, 2011 - Elsevier
Fibroblast growth factor 23 (FGF23) and parathyroid hormone blood levels rise following
progressive loss of renal function. Here we measured parameters of phosphate metabolism in …

[HTML][HTML] Urinary proteomic biomarkers for diagnosis and risk stratification of autosomal dominant polycystic kidney disease: a multicentric study

AD Kistler, AL Serra, J Siwy, D Poster, F Krauer… - PloS one, 2013 - journals.plos.org
Treatment options for autosomal dominant polycystic kidney disease (ADPKD) will likely
become available in the near future, hence reliable diagnostic and prognostic biomarkers for …

[HTML][HTML] Optimal respiratory syncytial virus intervention programmes using nirsevimab in England and Wales

D Hodgson, M Koltai, F Krauer, S Flasche, M Jit… - Vaccine, 2022 - Elsevier
Introduction Respiratory Syncytial Virus (RSV) is a major cause of acute lower respiratory
tract infections (ALRI) in infants. There are no licensed vaccines and only one monoclonal …

Soluble klotho and autosomal dominant polycystic kidney disease

…, P Jaeger, L Ebner, D Poster, F Krauer… - Clinical journal of the …, 2012 - journals.lww.com
Results ADPKD patients had 50% higher FGF23 levels than did XLH patients; TmP/GFR
was near normal in most ADPKD patients and very low in XLH patients. Serum Klotho levels …

[HTML][HTML] Determinants of RSV epidemiology following suppression through pandemic contact restrictions

M Koltai, F Krauer, D Hodgson, E van Leeuwen… - Epidemics, 2022 - Elsevier
Introduction COVID-19 related non-pharmaceutical interventions (NPIs) led to a suppression
of RSV circulation in winter 2020/21 in the UK and an off-season resurgence in Summer …